Table 3.
Pharmaceutical Purchasing challenges of Iranian Insurance Companies
| Themes | Sub Themes |
|---|---|
| Basic Benefit Package Challenges | Narrow pharmaceutical packages |
| Different pharmaceutical packages among various insurers | |
| Reimbursement Challenges | Incorrect cycle of funds in pharmaceutical section by theinsurers |
| Incorrect and long process of pharmaceuticalreimbursement | |
| Difference in payment ceilings for the same pharmaceuticals | |
| Difference in payment levels and payment mechanisms of pharmaceutical by various insurers | |
| Decision making Challenges | Existence of adverse selection and moral hazard in pharmaceutical sector |
| Lack of attention to cost effectiveness implications in pharmaceutical purchasing | |
| Technology Challenges | Force on applying new technologies and expensive pharmaceuticals |
| Devoting great costs to pharmaceutical sector and high technologies | |
| Contract Challenges | Lack of existence fair contracts for pharmaceutical purchasing |
| Lack of purchasing grand use pharmaceuticals through mass purchase | |
| Lack of ranking the pharmaceutical providers by policy makers |